You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Figure PPP-2. Indexed trends in EU potency/purity for major drug types, adjusting for population size, 2005-2010
| Year | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
|---|---|---|---|---|---|---|---|
| Cannabis resin | 100 | 96 | 95 | 99 | 99 | 101 | |
| Herbal cannabis | 100 | 88 | 75 | 87 | 105 | 131 | |
| Cocaine | 100 | 87 | 87 | 83 | 70 | 78 | |
| Amphetamines | 100 | 91 | 91 | 62 | 60 | 76 | |
| Ecstasy | 100 | 85 | 99 | 90 | 91 | 96 |
Notes:
1. The trends represent the available information on national potency / purity for each drug in the EU Member States, Croatia and Norway, weighted by country population sizes to form an overall EU trend. All series indexed to a base of 100 in 2005.
2. Countries missing drug price information for two or more consecutive years are not included in the trend calculations: the trend for amphetamine on twenty countries (68 % of the EU population 15-64), cocaine on twenty-three countries (83 % of the EU population 15-64), ecstasy on nineteen countries (70 % of the EU population 15-64), herbal cannabis on fourteen countries (58 % of the EU population 15-64), and cannabis resin on fifteen countries (57 % of the EU population 15-64). Trends for other drugs are not available due to insufficient data.
3. Additionally, where 2010 data are missing (one country) 2009 purity are used; for missing 2005 data (six countries) 2006 potency/purity data are used; data missing for other years (twelve countries) have been interpolated from adjacent years.
Sources:
Potency / purity data: Reitox National Focal Points
| Year | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Cannabis resin | 100 | 96 | 95 | 99 | 99 | 101 |
| Herbal cannabis | 100 | 88 | 75 | 87 | 105 | 131 |
| Cocaine | 100 | 87 | 87 | 83 | 70 | 78 |
| Amphetamines | 100 | 91 | 91 | 62 | 60 | 76 |
| Ecstasy | 100 | 85 | 99 | 90 | 91 | 96 |
pppfig2
| Demonstration | Reference | Type | Y Axis | X axis | Label | Width (%) | Height (px) | X plotline | Y plotline | Y min,max values | series Markers |
|---|---|---|---|---|---|---|---|---|---|---|---|
| szrfig1 | column,column,line | Quantity (kg)|Number of seizures$3 | |||||||||
| szrfig2 | column,column,line | Quantity (kg)|Number of seizures$3 | |||||||||
| gpsfig4a | line | % | 500 | 0,30 | |||||||
| gpsfig1 | column | % | 500 | 0,25 | |||||||
| gpsfig2 | column,column,point | Contiuation rates %|LTP all adults$3 | |||||||||
| gpsfig18a | distribution | Estimated prevalence (%) | 0 | ||||||||
| gpsfig18b | distribution | Estimated prevalence (%) | 0 | ||||||||
| gpsfig20 | column | % | 600 | 0,20 | |||||||
| dlofig2 | stackedBar | % | 600 | ||||||||
| dlofig3 | line | Index (2005 = 100) | 68 | ||||||||
| dlofig3$ | pie | 1 073 752 reports (2010) |
30 | ||||||||
| dlofig4 | line | Index (2005 = 100) | 68 | ||||||||
| dlofig4$ | pie | 1 073 752 reports (2010) | 30 | ||||||||
| dlofig5 | line | Index (2005 = 100) | 68 | ||||||||
| dlofig5$ | pie | 189 792 reports (2010) | 30 | ||||||||
| drdfig12a | scatter | Ratio between DRD in 2003 and 2000 | Number of DRD in 2000 | 1 | |||||||
| drdfig12b | scatter | Ratio between DRD in 2009/10 and 2003 | Number of DRD in 2003 | 1 | |||||||
| hsrfig2 | stackedColumn | Clients in substitution treatment | |||||||||
| dlofig1 | line | Index (2005 = 100) | 90,140 | ||||||||
| drdfig1 | column | Country and total number of DRD | 600 | ||||||||
| drdfig2 | column | Proportion of DRD under the age of 25 (%) | 600 | ||||||||
| drdfig3 | line | Mean age in years | |||||||||
| drdfig4 | line | Mean age in years | |||||||||
| drdfig5a | line | Index (1990 = 100) | |||||||||
| drdfig5b | line | Index (1996 = 100) | |||||||||
| drdfig6 | line | Index (1990 = 100 %) | 80,160 | ||||||||
| drdfig7a | column | Mortality rate per million | |||||||||
| drdfig7b | column,point | Rate per million | |||||||||
| drdfig8 | line | Index (1985 = 100 %) | 50,650 | ||||||||
| drdfig9a | line | % | 0,70 | ||||||||
| drdfig9b | line | % | |||||||||
| drdfig9c | line | % | |||||||||
| drdfig10 | column | Mean age in years | 500 | ||||||||
| drdfig11a | line | Index | 0,300 | ||||||||
| drdfig11b | line | Index | |||||||||
| drdfig11c | line | Index | |||||||||
| drdfig13a | line | Number of cases | |||||||||
| drdfig13b | line | Number of cases | |||||||||
| eyefig1a | line | ||||||||||
| eyefig1b | line | ||||||||||
| eyefig1c | line | 0, | |||||||||
| eyefig1d | line | % | 45 | 800 | |||||||
| eyefig1d$ | line | % | 45 | 800 | |||||||
| gpsfig3 | column | % | 500 | ||||||||
| gpsfig4b | line | % | |||||||||
| gpsfig5 | column | % | |||||||||
| gpsfig6 | column | % | |||||||||
| gpsfig7 | column | % | |||||||||
| gpsfig8a | line | % | 0, | ||||||||
| gpsfig8b | line | % | 0, | ||||||||
| gpsfig9a | column | % | |||||||||
| gpsfig9b | column | % | |||||||||
| gpsfig10 | line | % | |||||||||
| gpsfig11 | column,column,point | Continuation rates (%)| LTP All adults$3 | |||||||||
| gpsfig12a | line | % | 0, | ||||||||
| gpsfig12b | line | % | 0, | ||||||||
| gpsfig13 | column,column,point | % | |||||||||
| gpsfig14a | line | % | 0, | ||||||||
| gpsfig14b | line | % | 0, | ||||||||
| gpsfig15 | column | % | |||||||||
| gpsfig16 |
column,column,point |
Continuation rates (%)|LTP All adults$3 | 0, | ||||||||
| gpsfig17 | column | % | |||||||||
| gpsfig21a | line | % | 0, | ||||||||
| gpsfig21b | line | % | 0, | ||||||||
| gpsfig22 | column,column,point | Continuation rates (%)| LTP All adults$3 | |||||||||
| gpsfig23a | line | % | |||||||||
| gpsfig23b | line | % | |||||||||
| gpsfig23c | line | % | |||||||||
| gpsfig23d | line | % | 0, | ||||||||
| gpsfig23e | line | % | 0, | ||||||||
| hsrfig4 | pie | % of prison population in OST | 30 | ||||||||
| inffig1a | line | New AIDS cases per million population | 700 | 0, | |||||||
| inffig1b | line | New AIDS cases per million population | 700 | 0, | |||||||
| inffig2a | line | Cases per million population | 0, | ||||||||
|
inffig2b |
line |
Cases per million population | 0, | ||||||||
| inffig2c | line | Cases per million population | |||||||||
| inffig2d | line | Cases per million population | |||||||||
| inffig3a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig3b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig3c | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig6a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig6b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig6c | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig9a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| inffig9b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
| pppfig1 | line | Index (2005 = 100) | |||||||||
| pppfig2 | line | Index (2005 = 100) | |||||||||
| tdifig1a | line | % | |||||||||
| tdifig1b | line | ||||||||||
| tdifig2a | pie | 30 | |||||||||
| tdifig2b | pie | 50 | |||||||||
| tdifig3a | line | % | |||||||||
| tdifig3b | line | ||||||||||
| tdifig7 | line | % | 60 | 0, | |||||||
| tdifig7$ | stackedColumn | Numbers | 38 | ||||||||
| hsrfig1b | percentStackedColumn | % | |||||||||
| Distirbuted points with specific markers and colours | inffig6a | distribution | % | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||